“…[13] Screening of large corporate libraries, such as the Tres Cantos Antimalarial Set (TCAMS) from GSK, [14] also identified novel indole-based antimalarials that were used as starting points for the development of the next generation antimalarial lead compounds, such as 3-piperidin-4-yl-indoles 2. [15] Many other indole-related antimalarial chemotypes, including indoloquinolines 3, [16] indolizinoindolones 4, [17,18] indole-containing pyrazino[2,1b]quinazoline-3,6-diones 5, [19] and spirooxadiazoline oxindoles 6 [20] have emerged from academic settings.…”